Genomics and personalised whole-of-life healthcare.

Abstract:

:Genome sequencing has the potential for stratified cancer treatment and improved diagnostics for rare disorders. However, sequencing needs to be utilised in risk stratification on a population scale to deepen the impact on the health system by addressing common diseases, where individual genomic variants have variable penetrance and minor impact. As the accuracy of genomic risk predictors is bounded by heritability, environmental factors such as diet, lifestyle, and microbiome have to be considered. Large-scale, longitudinal research programmes need to study the intrinsic properties between both genetics and environment to unravel their risk contribution. During this discovery process, frameworks need to be established to counteract unrealistic expectations. Sufficient scientific evidence is needed to interpret sources of uncertainty and inform decision making for clinical management and personal health.

journal_name

Trends Mol Med

authors

Bauer DC,Gaff C,Dinger ME,Caramins M,Buske FA,Fenech M,Hansen D,Cobiac L

doi

10.1016/j.molmed.2014.04.001

subject

Has Abstract

pub_date

2014-09-01 00:00:00

pages

479-86

issue

9

eissn

1471-4914

issn

1471-499X

pii

S1471-4914(14)00062-8

journal_volume

20

pub_type

杂志文章,评审
  • iPSCs for personalized medicine: what will it take for Africa?

    abstract::Induced pluripotent stem cells (iPSCs) are cutting edge biotechnology that may revolutionize medicine, and creating iPSCs from ethnically diverse individuals would generate valuable therapeutic and drug development tools. However, challenges must be overcome in creating the infrastructure and scientific capacity neede...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2012.10.005

    authors: Fakunle ES

    更新日期:2012-12-01 00:00:00

  • Wound Repair, Scar Formation, and Cancer: Converging on Activin.

    abstract::Wound repair is a highly regulated process that requires the interaction of various cell types. It has been shown that cancers use the mechanisms of wound healing to promote their own growth. Therefore, it is of importance to identify common regulators of wound repair and tumor formation and to unravel their functions...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2020.07.009

    authors: Cangkrama M,Wietecha M,Werner S

    更新日期:2020-12-01 00:00:00

  • Integrating germline and somatic data towards a personalized cancer medicine.

    abstract::In recent years there have been major advances in the knowledge of the genetic alterations that drive cancer susceptibility and progression. However, the molecular links between these alteration levels (i.e., germline for susceptibility and somatic for progression) remain mostly unknown. Here, the potential of integra...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2014.05.004

    authors: Pujana MA

    更新日期:2014-08-01 00:00:00

  • Pregnancy Around the Clock.

    abstract::A recent study introduced the existence of an 'immune clock' in pregnancy; during the course of gestation, peripheral blood cells from pregnant women were analyzed by mass cytometry using a single-cell signaling-based elastic net algorithm. The insights will undoubtedly promote the testing of such a clock - possibly i...

    journal_title:Trends in molecular medicine

    pub_type: 评论,杂志文章

    doi:10.1016/j.molmed.2017.11.007

    authors: Diemert A,Arck PC

    更新日期:2018-01-01 00:00:00

  • BRCA2: breaks, mistakes and failed separations.

    abstract::BRCA2 was identified in 1995, one year after BRCA1. In terms of knowledge of the function of its product, BRCA2 has remained the less well-characterised gene. Both BRCA1 and BRCA2 are closely implicated in the repair of double-strand breaks in DNA by homologous recombination, but beyond that a function for BRCA2 has b...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2005.02.003

    authors: Rudkin TM,Foulkes WD

    更新日期:2005-04-01 00:00:00

  • Advances in epigenome-wide association studies for common diseases.

    abstract::Epigenome-wide association studies (EWASs) provide a systematic approach to uncovering epigenetic variants underlying common diseases. Discoveries have shed light on novel molecular mechanisms of disease and enabled the application of epigenetic variants as biomarkers. Here, we highlight the recent advances in this em...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2014.07.002

    authors: Paul DS,Beck S

    更新日期:2014-10-01 00:00:00

  • Boosting Antitumour Immunity through Targeted Delivery of Interferon-α.

    abstract::Immune checkpoint inhibitors (ICIs) have revolutionised cancer immunotherapy but their success is wholly dependent on amplifying an existing immune response directed against the tumour. A recent study by Tsuchiya et al. suggests how the properties of induced pluripotent stem cells (iPSCs) may be exploited for the targ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2019.09.001

    authors: Fairchild PJ,Davies TJ

    更新日期:2019-11-01 00:00:00

  • Harnessing the potential of myogenic satellite cells.

    abstract::Adult skeletal muscle has remarkable regenerative potential, which is mainly attributable to a small population of undifferentiated skeletal muscle precursors called satellite cells. These cells reside underneath the basal lamina of skeletal myofibers and can be activated to proliferate, differentiate and fuse to form...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2006.03.002

    authors: Sherwood RI,Wagers AJ

    更新日期:2006-05-01 00:00:00

  • Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes.

    abstract::It is now widely accepted that the classic environmental risk factors for atherosclerosis only partly explain the incidence of coronary artery disease and the development of acute coronary syndromes. Therefore, genetic factors that vary among human populations seem to be involved in the clinical manifestations of such...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2008.08.004

    authors: Tousoulis D,Briasoulis A,Papageorgiou N,Antoniades C,Stefanadis C

    更新日期:2008-10-01 00:00:00

  • Antipsychotic drugs and obesity.

    abstract::Mechanisms underlying antipsychotic cardiometabolic adverse effects are incompletely understood. This hampers the identification of high-risk patients, low-risk antipsychotics and preventive/ameliorative treatments. Recent clinical, molecular and genetic data suggest that: (i) antipsychotic-naïve samples provide the g...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2010.10.010

    authors: Correll CU,Lencz T,Malhotra AK

    更新日期:2011-02-01 00:00:00

  • Novel Immunotherapeutic Avenues for Rheumatoid Arthritis.

    abstract::Rheumatoid arthritis (RA) is the most common inflammatory rheumatic disease. It leads to irreversible joint damage, physical handicap, and reduced life expectancy. The past two decades have seen considerable therapeutic advances with the development of biologic treatments to block proinflammatory cytokines or modulate...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2016.01.005

    authors: Semerano L,Minichiello E,Bessis N,Boissier MC

    更新日期:2016-03-01 00:00:00

  • Signaling to NF-kappaB by Toll-like receptors.

    abstract::Innate immunity is the first line of defense against invading pathogens. A family of Toll-like receptors (TLRs) acts as primary sensors that detect a wide variety of microbial components and elicit innate immune responses. All TLR signaling pathways culminate in activation of the transcription factor nuclear factor-ka...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2007.09.002

    authors: Kawai T,Akira S

    更新日期:2007-11-01 00:00:00

  • Brain iron transport and neurodegeneration.

    abstract::Despite years of investigation, it is still not known why iron levels are abnormally high in some regions of the brain in neurodegenerative disorders. Also, it is not clear whether iron accumulation in the brain is an initial event that causes neuronal death or is a consequence of the disease process. Here, we propose...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4914(00)01910-9

    authors: Qian ZM,Shen X

    更新日期:2001-03-01 00:00:00

  • Dispelling myths and focusing on notable concepts in HIV pathogenesis.

    abstract::Since the discovery of HIV over three decades ago, major efforts have been made to control and perhaps eliminate HIV infection worldwide. During these studies, certain myths or misconceptions about this infectious disease have been emphasized and other potentially beneficial concepts have received less attention. A tr...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2015.03.004

    authors: Levy JA

    更新日期:2015-06-01 00:00:00

  • Meet Your Stress Management Professionals: The Endocannabinoids.

    abstract::The endocannabinoid signaling system (ECSS) is altered by exposure to stress and mediates and modulates the effects of stress on the brain. Considerable preclinical data support critical roles for the endocannabinoids and their target, the CB1 cannabinoid receptor, in the adaptation of the brain to repeated stress exp...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2020.07.002

    authors: deRoon-Cassini TA,Stollenwerk TM,Beatka M,Hillard CJ

    更新日期:2020-10-01 00:00:00

  • Lessons from models of SOD1-linked familial ALS.

    abstract::Ten years ago, the linkage between mutations in the gene coding for the antioxidant enzyme Cu,Zn superoxide dismutase (SOD1) and the neurodegenerative disease known as familial amyotrophic lateral sclerosis (FALS) was established. This finding has prompted a myriad of new studies in experimental models aimed at invest...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2004.06.009

    authors: Bendotti C,Carrì MT

    更新日期:2004-08-01 00:00:00

  • Sense from nonsense: therapies for premature stop codon diseases.

    abstract::Ten percent of inherited diseases are caused by premature termination codon (PTC) mutations that lead to degradation of the mRNA template and to the production of a non-functional, truncated polypeptide. In addition, many acquired mutations in cancer introduce similar PTCs. In 1999, proof-of-concept for treating these...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2012.09.008

    authors: Bidou L,Allamand V,Rousset JP,Namy O

    更新日期:2012-11-01 00:00:00

  • Putting the brakes on anticancer therapies: suppression of innate immune pathways by tumor-associated myeloid cells.

    abstract::Accumulating evidence has revealed that immunogenic cell death triggered by particular chemotherapeutic agents plays a critical role in harnessing antitumor immunity to clinical responses. However, negative regulatory pathways exist which suppress the induction of effective immune responses by a broad spectrum of anti...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2013.06.001

    authors: Jinushi M,Yagita H,Yoshiyama H,Tahara H

    更新日期:2013-09-01 00:00:00

  • EphrinB2-EphB4-RASA1 Signaling in Human Cerebrovascular Development and Disease.

    abstract::Recent whole exome sequencing studies in humans have provided novel insight into the importance of the ephrinB2-EphB4-RASA1 signaling axis in cerebrovascular development, corroborating and extending previous work in model systems. Here, we aim to review the human cerebrovascular phenotypes associated with ephrinB2-Eph...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2019.01.009

    authors: Zeng X,Hunt A,Jin SC,Duran D,Gaillard J,Kahle KT

    更新日期:2019-04-01 00:00:00

  • Immunotherapy: target the stroma to hit the tumor.

    abstract::For decades it has been assumed that T cells reject tumors essentially by direct killing. However, solid tumors are composed of malignant cells and a variety of different nonmalignant cells, referred to as tumor stroma. Stromal cells, such as endothelial cells, fibroblasts and inflammatory cells, often support tumor g...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2005.03.002

    authors: Kammertoens T,Schüler T,Blankenstein T

    更新日期:2005-05-01 00:00:00

  • Molecular targeting of glioblastoma: Drug discovery and therapies.

    abstract::Despite advances in treatment for glioblastoma multiforme (GBM), patient prognosis remains poor. Although there is growing evidence that molecular targeting could translate into better survival for GBM, current clinical data show limited impact on survival. Recent progress in GBM genomics implicate several activated p...

    journal_title:Trends in molecular medicine

    pub_type: 临床试验,杂志文章,评审

    doi:10.1016/j.molmed.2011.01.011

    authors: Bai RY,Staedtke V,Riggins GJ

    更新日期:2011-06-01 00:00:00

  • Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty.

    abstract::Theoretical, desirable features of second-generation metal-on-metal (MoM) hip prostheses have led to their widespread use. However, the bearing surfaces, consisting of complex cobalt-chromium alloys, are subject to wear and the release of cobalt and chromium (CoCr) nanoparticles. These nanoparticles can reduce cellula...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2011.12.002

    authors: Gill HS,Grammatopoulos G,Adshead S,Tsialogiannis E,Tsiridis E

    更新日期:2012-03-01 00:00:00

  • Challenges and Opportunities for Translation of Therapies to Improve Cognition in Down Syndrome.

    abstract::While preclinical studies have reported improvement of behavioral deficits in the Ts65Dn mouse model of Down syndrome (DS), translation to human clinical trials to improve cognition in individuals with DS has had a poor success record. Timing of the intervention, choice of animal models, strategy for drug selection, a...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2019.10.001

    authors: Lee SE,Duran-Martinez M,Khantsis S,Bianchi DW,Guedj F

    更新日期:2020-02-01 00:00:00

  • Towards a molecular understanding of human diseases using Dictyostelium discoideum.

    abstract::The social amoeba Dictyostelium discoideum is increasingly being used as a simple model for the investigation of problems that are relevant to human health. This article focuses on several recent examples of Dictyostelium-based biomedical research, including the analysis of immune-cell disease and chemotaxis, centroso...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2006.07.003

    authors: Williams RS,Boeckeler K,Gräf R,Müller-Taubenberger A,Li Z,Isberg RR,Wessels D,Soll DR,Alexander H,Alexander S

    更新日期:2006-09-01 00:00:00

  • Do Microglial Sex Differences Contribute to Sex Differences in Neurodegenerative Diseases?

    abstract::Sex differences have been clinically documented in numerous neurodegenerative diseases and yet the reasons for these differences are not well understood. Recent studies have found that microglia, the innate immune cells of the central nervous system, are a key cell type involved in neurodegenerative diseases. This cel...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2019.05.001

    authors: Kodama L,Gan L

    更新日期:2019-09-01 00:00:00

  • Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad?

    abstract::MALT1 is a signaling protein that plays a key role in immunity, inflammation, and lymphoid malignancies. For a long time MALT1 was believed to function as a scaffold protein, providing an assembly platform for other signaling proteins. This view changed dramatically when MALT1 was also found to have proteolytic activi...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2015.12.004

    authors: Demeyer A,Staal J,Beyaert R

    更新日期:2016-02-01 00:00:00

  • Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises.

    abstract::Medical diagnosis and phenotyping increasingly incorporate information from complex biological samples. This has promoted the development and clinical application of non-invasive metabolomics in exhaled air (breathomics). In respiratory medicine, expired volatile organic compounds (VOCs) are associated with inflammato...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2015.08.001

    authors: Boots AW,Bos LD,van der Schee MP,van Schooten FJ,Sterk PJ

    更新日期:2015-10-01 00:00:00

  • Association of PADI4 and rheumatoid arthritis: a successful multidisciplinary approach.

    abstract::The identification of functionally relevant polymorphisms of peptidylarginine deiminase 4, an enzyme that catalyzes the post-translational citrullination of proteins, as a rheumatoid arthritis gene is one of the most convincing success stories of complex disease gene mapping to date. In addition to an extensive single...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.molmed.2003.08.007

    authors: Worthington J,John S

    更新日期:2003-10-01 00:00:00

  • Fumarates and Cancer.

    abstract::Accumulation of intermediate metabolites of the tricarboxylic acid (TCA) cycle in tumor cells can cause epithelial-to-mesenchymal transition (EMT), although the exact mechanisms remain elusive. Recent studies show that the oncometabolite fumarate, which accumulates in fumarate hydratase-deficient renal cancers, confer...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2016.12.001

    authors: Fuhler GM,Eppinga H,Peppelenbosch MP

    更新日期:2017-01-01 00:00:00

  • B cell responses to HIV-1 infection and vaccination: pathways to preventing infection.

    abstract::The B cell arm of the immune response becomes activated soon after HIV-1 transmission, yet the initial antibody response does not control HIV-1 replication, and it takes months for neutralizing antibodies to develop against the autologous virus. Antibodies that can be broadly protective are made only in a minority of ...

    journal_title:Trends in molecular medicine

    pub_type: 杂志文章

    doi:10.1016/j.molmed.2010.10.008

    authors: Haynes BF,Moody MA,Liao HX,Verkoczy L,Tomaras GD

    更新日期:2011-02-01 00:00:00